13F HOLDINGS REPORT
Pfizer Inc
Quarter ended Q2 2025 · Filed August 11, 2025 · Accession 0000078003-25-000142
Total Value
$576.2M
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BIONTECH SE | BNTX | 3,658,361 | $389.5M | 67.60% |
| 2 | ORIC PHARMACEUTICALS INC | ORIC | 5,376,344 | $54.6M | 9.47% |
| 3 | ARVINAS INC | ARVN | 3,457,815 | $25.4M | 4.42% |
| 4 | ALLOGENE THERAPEUTICS INC | ALLO | 22,032,040 | $24.9M | 4.32% |
| 5 | TOURMALINE BIO INC | 89157D105 | 1,272,214 | $20.3M | 3.53% |
| 6 | WAVE LIFE SCIENCES LTD | WVE | 1,875,000 | $12.2M | 2.12% |
| 7 | CARDIFF ONCOLOGY INC | CRDF | 2,411,575 | $7.6M | 1.32% |
| 8 | BIOHAVEN LTD | BHVN | 505,645 | $7.1M | 1.24% |
| 9 | SPERO THERAPEUTICS INC | SPRO | 2,362,348 | $6.9M | 1.19% |
| 10 | PYXIS ONCOLOGY INC | PYXS | 5,952,263 | $6.5M | 1.14% |
| 11 | CARIBOU BIOSCIENCES INC | CRBU | 4,690,431 | $5.9M | 1.03% |
| 12 | CELCUITY INC | CELC | 349,406 | $4.7M | 0.81% |
| 13 | ZURA BIO LTD | ZURA | 2,970,022 | $3.1M | 0.54% |
| 14 | ESSA PHARMA INC | 29668H708 | 1,675,000 | $2.8M | 0.49% |
| 15 | PYXIS ONCOLOGY INC | PYXS | 1,080,507 | $1.2M | 0.21% |
| 16 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 953,834 | $1.1M | 0.19% |
| 17 | AN2 THERAPEUTICS INC | ANTX | 715,295 | $758,213 | 0.13% |
| 18 | NEXTCURE INC | NXTC | 131,109 | $723,722 | 0.13% |
| 19 | Q32 BIO INC | QTTB | 277,777 | $413,888 | 0.07% |
| 20 | BOLT BIOTHERAPEUTICS INC | BOLT | 31,305 | $180,630 | 0.03% |
| 21 | NEXTCURE INC | NXTC | 26,537 | $146,484 | 0.03% |
| 22 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 2,681 | $30,161 | 0.01% |
| 23 | SENSEONICS HLDGS INC | SENS | 43,426 | $20,671 | 0.00% |
| 24 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 247 | $2,779 | 0.00% |